1. Home
  2. ASTE vs GYRE Comparison

ASTE vs GYRE Comparison

Compare ASTE & GYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASTE
  • GYRE
  • Stock Information
  • Founded
  • ASTE 1972
  • GYRE 2002
  • Country
  • ASTE United States
  • GYRE United States
  • Employees
  • ASTE N/A
  • GYRE N/A
  • Industry
  • ASTE Construction/Ag Equipment/Trucks
  • GYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASTE Industrials
  • GYRE Health Care
  • Exchange
  • ASTE Nasdaq
  • GYRE Nasdaq
  • Market Cap
  • ASTE 836.1M
  • GYRE 990.4M
  • IPO Year
  • ASTE N/A
  • GYRE N/A
  • Fundamental
  • Price
  • ASTE $35.03
  • GYRE $9.11
  • Analyst Decision
  • ASTE Hold
  • GYRE
  • Analyst Count
  • ASTE 2
  • GYRE 0
  • Target Price
  • ASTE $39.00
  • GYRE N/A
  • AVG Volume (30 Days)
  • ASTE 150.6K
  • GYRE 210.8K
  • Earning Date
  • ASTE 04-30-2025
  • GYRE 03-17-2025
  • Dividend Yield
  • ASTE 1.47%
  • GYRE N/A
  • EPS Growth
  • ASTE N/A
  • GYRE N/A
  • EPS
  • ASTE 0.19
  • GYRE 0.05
  • Revenue
  • ASTE $1,305,100,000.00
  • GYRE $105,757,000.00
  • Revenue This Year
  • ASTE $6.05
  • GYRE $51.85
  • Revenue Next Year
  • ASTE $4.34
  • GYRE $29.83
  • P/E Ratio
  • ASTE $190.40
  • GYRE $189.07
  • Revenue Growth
  • ASTE N/A
  • GYRE N/A
  • 52 Week Low
  • ASTE $28.46
  • GYRE $8.26
  • 52 Week High
  • ASTE $44.74
  • GYRE $19.00
  • Technical
  • Relative Strength Index (RSI)
  • ASTE 47.17
  • GYRE 40.54
  • Support Level
  • ASTE $35.27
  • GYRE $8.65
  • Resistance Level
  • ASTE $37.23
  • GYRE $9.50
  • Average True Range (ATR)
  • ASTE 1.04
  • GYRE 0.97
  • MACD
  • ASTE -0.15
  • GYRE -0.18
  • Stochastic Oscillator
  • ASTE 3.26
  • GYRE 15.01

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

About GYRE Gyre Therapeutics Inc.

Gyre Therapeutics Inc is a biopharmaceutical company headquartered in San Diego, CA, that is primarily focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis), formerly known as Nonalcoholic Steatohepatitis (NASH)) in the United States. In the United States, Hydronidone is currently being evaluated for the treatment of liver fibrosis across a broad spectrum of chronic liver diseases under an active Investigational New Drug (IND) application. Gyre is also advancing a diverse pipeline in China through a controlling interest in the Beijing Continent, including pirfenidone, F573, F528, and F230.

Share on Social Networks: